Free Trial

Haemonetics (HAE) Insider Trading & Ownership

Haemonetics logo
$62.98 -0.47 (-0.75%)
Closing price 03:59 PM Eastern
Extended Trading
$63.18 +0.21 (+0.33%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Haemonetics (NYSE:HAE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$3.03 M
Get HAE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Haemonetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HAE Insider Buying and Selling by Quarter

Haemonetics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/26/2024Stewart W StrongInsiderSell4,312$91.15$393,038.80  
7/11/2024Anila LingamneniEVPSell2,136$90.00$192,240.00  
5/29/2024Michelle L BasilEVPSell12,990$88.08$1,144,159.20  
5/29/2024Stewart W StrongInsiderSell8,857$87.53$775,253.21  
5/20/2024Josep LlorensEVPSell987$95.08$93,843.96  
5/20/2024Stewart W StrongInsiderSell686$95.11$65,245.46  
5/17/2024Josep LlorensEVPSell822$94.82$77,942.04  
5/16/2024Stewart W StrongInsiderSell733$96.04$70,397.32  
5/6/2024Anila LingamneniEVPSell2,305$95.00$218,975.00  
(Data available from 1/1/2013 forward)

HAE Insider Trading Activity - Frequently Asked Questions

1.80% of Haemonetics stock is owned by insiders. Learn more on HAE's insider holdings.

The following insiders have sold HAE shares in the last 24 months: Anila Lingamneni ($810,657.32), Josep Llorens ($615,306.00), Michelle L Basil ($1,144,159.20), and Stewart W Strong ($1,324,602.99).

Insiders have sold a total of 43,593 Haemonetics shares in the last 24 months for a total of $3,894,725.51 sold.

Haemonetics Key Executives



This page (NYSE:HAE) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners